Tech Company Financing Transactions

ReGen Biologics Funding Round

On 3/31/2007, ReGen Biologics raised $3 million in financing from Sanderling Ventures.

Transaction Overview

Company Name
Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors

Sanderling Ventures (Robert McNeil)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
411 Hackensack Avenue
Hackensack, NJ 07601
USA
Email Address
Overview
Develops implantable regeneration templates for knee meniscal cartilage.
Profile
ReGen Biologics LinkedIn Company Profile
Social Media
ReGen Biologics Company Twitter Account
Company News
ReGen Biologics News
Facebook
ReGen Biologics on Facebook
YouTube
ReGen Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gerald Bisbee
  Gerald Bisbee LinkedIn Profile  Gerald Bisbee Twitter Account  Gerald Bisbee News  Gerald Bisbee on Facebook
Chief Financial Officer
Brion Umidi
  Brion Umidi LinkedIn Profile  Brion Umidi Twitter Account  Brion Umidi News  Brion Umidi on Facebook
VP - Regulatory Affairs
John Dichiara
  John Dichiara LinkedIn Profile  John Dichiara Twitter Account  John Dichiara News  John Dichiara on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2007: FoldRx Pharmaceuticals venture capital transaction
Next: 3/31/2007: Alphion venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary